The ADANCE -LSB- Apixaban Versus Dual-antiplatelet Therapy ( Clopidogrel and Aspirin ) in Acute Non-disabling Cerebrovascular Events -RSB- study is a randomized , double-blind clinical trial with a target enrollment of @,@ patients .